The therapeutic effect of FTY720 on lupus nephritis in autoimmune MRL/lpr mice

被引：0
|
作者：
Sugahara, K [1 ]
Kataoka, H [1 ]
Ohtsuki, M [1 ]
Hoshino, Y [1 ]
Chiba, K [1 ]
机构：
[1] Mitsubishi Pharma Corp, Res Lab 3, Pharmaceut Res Unit, Div Res & Dev, Yokohama, Kanagawa, Japan
来源：
IMMUNOLOGY 2004: AUTOIMMUNITY, GENETIC AND DEGENERATIVE DISORDERS, MALIGNANCIES, AND TRANSPLANTATION | 2004年
关键词：
D O I：
暂无
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
Sphingosine 1-phosphate receptor agonist, FTY720 at oral doses of 0.03 to 1 mg/kg exhibited the prophylactic and therapeutic effect on lupus nephritis spontaneously developed in MRL/lpr mice. The therapeutical administration of FTY720 resulted in a decrease in the number of T cells, especially CD4(+) T cells, infiltrated into kidney as well as reduction of lymphocytes in blood. Moreover, the elevation of Th1 cytokine/chemokine mRNA expression was decreased in kidneys of FTY720-treated group. These results suggest that FTY720 decreases autoreactive Th1 cell infiltration into kidneys by reduction of circulating lymphocytes in blood, and thereby shows a marked therapeutic effect on progressing lupus nephritis of MRL/lpr mice.
引用
收藏
页码：271 / 274
页数：4
相关论文
共 50 条
  • [1] Effects of FTY720 in MRL-lpr/lpr mice: Therapeutic potential in systemic lupus erythematosus
    Okazaki, H
    Hirata, D
    Kamimura, T
    Sato, H
    Iwamoto, M
    Yoshio, T
    Masuyama, J
    Fujimura, A
    Kobayashi, E
    Kano, S
    Minota, S
    JOURNAL OF RHEUMATOLOGY, 2002, 29 (04) : 707 - 716
  • [2] The therapeutic effect of FTY720 on experimental autoimmune encephalomyelitis in mice
    Kataoka, H
    Sugahara, K
    Tanaka, H
    Ohtsuki, M
    Maeda, Y
    Murata, M
    Shimano, K
    Chiba, K
    IMMUNOLOGY 2004: AUTOIMMUNITY, GENETIC AND DEGENERATIVE DISORDERS, MALIGNANCIES, AND TRANSPLANTATION, 2004, : 87 - 89
  • [3] The in vivo induction of lymphocyte apoptosis in MRL-lpr/lpr mice treated with FTY720
    Suzuki, S
    Li, XK
    Shinomiya, T
    Enosawa, S
    Amemiya, H
    Amari, M
    Naoe, S
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1997, 107 (01): : 103 - 111
  • [4] Therapeutic effects of C2-Ceramide and FTY720 on the clinical course of MRL-lpr/lpr mice.
    Okazaki, H
    Hirata, D
    Kamimura, T
    Sato, H
    Kano, S
    Minota, S
    ARTHRITIS AND RHEUMATISM, 1998, 41 (09): : S175 - S175
  • [5] EFFECT OF MACROPHAGE ACTIVATION ON LUPUS NEPHRITIS IN MRL/MPJ-LPR/LPR(MRL/L)MICE
    IZUMINO, K
    FUTAMURA, A
    NAKAGAWA, Y
    ENTANI, C
    TAKATA, M
    INOUE, H
    IIDA, H
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1995, 6 (03): : 870 - 870
  • [6] Amelioration of autoimmune nephritis by imatinib in MRL/lpr mice
    Sadanaga, A
    Nakashima, H
    Masutani, K
    Miyake, K
    Shimizu, S
    Igawa, T
    Sugiyama, N
    Niiro, H
    Hirakata, H
    Harada, M
    ARTHRITIS AND RHEUMATISM, 2005, 52 (12): : 3987 - 3996
  • [7] Prevention of autoimmune diabetes by FTY720 in nonobese diabetic mice
    Maki, T
    Gottschalk, R
    Monaco, AP
    TRANSPLANTATION, 2002, 74 (12) : 1684 - 1686
  • [8] Evaluation of Experimental Autoimmune Uveitis in Mice Treated with FTY720
    Commodaro, Alessandra Goncalves
    Peron, Jean Pierre S.
    Lopes, Camila Takao
    Arslanian, Christina
    Belfort, Rubens, Jr.
    Rizzo, Luiz Vicente
    Bueno, Valquiria
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (05) : 2568 - 2574
  • [9] Inhibitory oligodeoxynucleotide inhibits the progression of autoimmune nephritis in the lupus prone MRL-lpr/lpr mice.
    Hoshi, N
    Watanabe, H
    Kobayashi, H
    Sato, Y
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S627 - S628
  • [10] ALW peptide ameliorates lupus nephritis in MRL/lpr mice
    Huixia Wang
    Mei Lu
    Siyue Zhai
    Kunyi Wu
    Lingling Peng
    Jie Yang
    Yumin Xia
    Arthritis Research & Therapy, 21
12345